Association Between Memory B-cells and Clinical and Immunological Features of Primary Sjögren's Syndrome and Sicca Patients
- PMID: 29623391
- DOI: 10.1007/s00296-018-4018-0
Association Between Memory B-cells and Clinical and Immunological Features of Primary Sjögren's Syndrome and Sicca Patients
Abstract
B-cells play a pivotal role in primary Sjögren's syndrome (pSS) pathogenesis. We aim to (1) evaluate the distribution of B-lymphocyte subpopulations in pSS and Sicca patients, (2) establish cut-off points that discriminate pSS from controls, (3) evaluate the association between memory B-cells and phenotypic features in pSS. We included 57 pSS patients, 68 Sicca and 24 healthy controls. Circulating B-cells were characterized by flow cytometry as naïve and memory subsets and classified from Bm1 to Bm5. Compared to controls, pSS patients had lower percentages (29.5 vs 44.4%) and absolute numbers (47 vs 106 cells/µl) of memory B-cells. Through ROC curves, a cut-off of ≤ 58 total memory B-cells/µl yielded a specificity of 0.88 and a sensitivity of 0.60 for pSS, and was met by 59.6% of pSS patients, 38.8% of Sicca and 12.5% of controls. A cut-off of < 23.5 Switched-memory B-cells/µl yielded a specificity of 0.88 and a sensitivity of 0.54 and was met by 54.4% of pSS patients, 37.3% of Sicca and 12.5% of controls. In pSS, lower total memory B-cells count was associated with longer disease duration (14.3 vs 8.1 years, p = 0.006) and more active disease profile, as evaluated by the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activity Index (ESSDAI) (3.1 vs 1.4, p = 0.043). Decreased numbers of memory B-cells clearly discriminated pSS from controls and can also have prognostic value. It remains to be clarified whether Sicca patients with decreased memory B-cells represent pSS and if B-cell profiling could help in the diagnosis of pSS.
Keywords: Autoimmunity; Diagnosis; Flow cytometry; Memory B cells; Sjögren’s syndrome.
Similar articles
-
Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.PLoS One. 2019 Dec 31;14(12):e0226498. doi: 10.1371/journal.pone.0226498. eCollection 2019. PLoS One. 2019. PMID: 31891590 Free PMC article.
-
Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):157-164. Epub 2018 Feb 15. Clin Exp Rheumatol. 2018. PMID: 29465360
-
Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.Arthritis Rheumatol. 2014 Sep;66(9):2558-69. doi: 10.1002/art.38734. Arthritis Rheumatol. 2014. PMID: 24909310 Free PMC article.
-
Primary Sjögren's syndrome.Best Pract Res Clin Rheumatol. 2016 Feb;30(1):189-220. doi: 10.1016/j.berh.2016.04.003. Epub 2016 May 13. Best Pract Res Clin Rheumatol. 2016. PMID: 27421224 Review.
-
Primary Sjogren's syndrome: current and prospective therapies.Semin Arthritis Rheum. 2008 Apr;37(5):273-92. doi: 10.1016/j.semarthrit.2007.06.002. Epub 2007 Aug 21. Semin Arthritis Rheum. 2008. PMID: 17714766 Review.
Cited by 1 article
-
Update on Sjögren's Syndrome 2018.Mediterr J Rheumatol. 2018 Dec 18;29(4):193-198. doi: 10.31138/mjr.29.4.193. eCollection 2018 Dec. Mediterr J Rheumatol. 2018. PMID: 32185326 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
